hybrid CF (Hybrid-Rx LLC)
Welcome to the PulseAid listing for the hybrid CF drug offered from Hybrid-Rx LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hybrid-Rx LLC |
| NON-PROPRIETARY NAME: | APAP 500 mg Phenylephrine HCL 5 mg Chlorpheniramine maleate 2 mg |
| SUBSTANCE NAME: | ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2010-02-03 |
| END MARKETING DATE: | 0000-00-00 |
hybrid CF HUMAN OTC DRUG Details:
| Item Description | hybrid CF from Hybrid-Rx LLC |
| LABELER NAME: | Hybrid-Rx LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500; 5; 2(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2010-02-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49804-101_5e3e64e8-adb5-4072-a226-732d7ca75f57 |
| PRODUCT NDC: | 49804-101 |
| APPLICATION NUMBER: | part341 |
Other ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE Pharmaceutical Manufacturers / Labelers:
